Literature DB >> 2025844

Late renal dysfunction in adult survivors of bone marrow transplantation.

C A Lawton1, E P Cohen, S W Barber-Derus, K J Murray, R C Ash, J T Casper, J E Moulder.   

Abstract

Until recently long-term renal toxicity has not been considered a major late complication of bone marrow transplantation (BMT). Late renal dysfunction has been described in a pediatric population status post-BMT which was attributable to the radiation in the preparatory regimen. A thorough review of adults with this type of late renal dysfunction has not previously been described. Fourteen of 103 evaluable adult patients undergoing allogeneic (96) or autologous (7) bone marrow transplantation, predominantly for leukemia and lymphomas, at the Medical College of Wisconsin (Milwaukee, WI) have had a syndrome of renal insufficiency characterized by increased serum creatinine, decreased glomerular filtration rate, anemia, and hypertension. This syndrome developed at a median of 9 months (range, 4.5 to 26 months) posttransplantation in the absence of specific identifiable causes. The cumulative probability of having this renal dysfunction is 20% at 1 year. Renal biopsies performed on seven of these cases showed the endothelium widely separated from the basement membrane, extreme thickening of the glomerular basement membrane, and microthrombi. Previous chemotherapy, antibiotics, and antifungals as well as cyclosporin may add to and possibly potentiate a primary chemoradiation marrow transplant renal injury, but this clinical syndrome is most analogous to clinical and experimental models of radiation nephritis. This late marrow transplant-associated nephritis should be recognized as a potentially limiting factor in the use of some intensive chemoradiation conditioning regimens used for BMT. Some selective attenuation of the radiation to the kidneys may decrease the incidence of this renal dysfunction.

Entities:  

Mesh:

Year:  1991        PMID: 2025844     DOI: 10.1002/1097-0142(19910601)67:11<2795::aid-cncr2820671114>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

Review 1.  Genitourinary long-term outcomes for childhood cancer survivors.

Authors:  Margarett Shnorhavorian; Debra L Friedman; Martin A Koyle
Journal:  Curr Urol Rep       Date:  2009-03       Impact factor: 3.092

Review 2.  Renal dysfunction following bone marrow transplantation.

Authors:  Stephan Kemmner; Mareike Verbeek; Uwe Heemann
Journal:  J Nephrol       Date:  2016-09-02       Impact factor: 3.902

3.  Radiation-induced chronic oxidative renal damage can be reduced by amifostine.

Authors:  Rusen Cosar; Vuslat Yurut-Caloglu; Sevgi Eskiocak; Alaattin Ozen; Semsi Altaner; Kamuran Ibis; Nesrin Turan; Bengu Denizli; Cem Uzal; Mert Saynak; Sule Parlar; Murat Caloglu; Burcu Uregen; Zafer Kocak
Journal:  Med Oncol       Date:  2011-02-24       Impact factor: 3.064

Review 4.  Kidney transplantation for treatment of end-stage kidney disease after haematopoietic stem cell transplantation: case series and literature review.

Authors:  Akihiro Tsuchimoto; Kosuke Masutani; Kazuya Omoto; Masayoshi Okumi; Yasuhiro Okabe; Takehiro Nishiki; Morihito Ota; Toshiaki Nakano; Kazuhiko Tsuruya; Takanari Kitazono; Masafumi Nakamura; Hideki Ishida; Kazunari Tanabe
Journal:  Clin Exp Nephrol       Date:  2018-12-24       Impact factor: 2.801

5.  Pediatric Onco-Nephrology: Time to Spread the Word-Part II: Long-Term Kidney Outcomes in Survivors of Childhood Malignancy and Malignancy after Kidney Transplant.

Authors:  Arwa Nada; Jennifer G Jetton
Journal:  Pediatr Nephrol       Date:  2021-09-06       Impact factor: 3.651

Review 6.  Renal function following hematological stem cell transplantation in childhood.

Authors:  Ludwig Patzer; Karim Kentouche; Felix Ringelmann; Joachim Misselwitz
Journal:  Pediatr Nephrol       Date:  2003-04-29       Impact factor: 3.714

Review 7.  Chronic kidney disease after hematopoietic cell transplantation: a systematic review.

Authors:  M J Ellis; C R Parikh; J K Inrig; M Kanbay; M Kambay; U D Patel
Journal:  Am J Transplant       Date:  2008-11       Impact factor: 8.086

8.  Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation.

Authors:  Michael Choi; Can-Lan Sun; Seira Kurian; Andrea Carter; Liton Francisco; Stephen J Forman; Smita Bhatia
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

Review 9.  Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell Transplantation.

Authors:  Amanda DeMauro Renaghan; Edgar A Jaimes; Jolanta Malyszko; Mark A Perazella; Ben Sprangers; Mitchell Howard Rosner
Journal:  Clin J Am Soc Nephrol       Date:  2019-12-13       Impact factor: 8.237

Review 10.  Solid organ transplantation following end-organ failure in recipients of hematopoietic stem cell transplantation in children.

Authors:  Kiran Upadhyay; Richard N Fine
Journal:  Pediatr Nephrol       Date:  2013-08-16       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.